BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 9113247)

  • 1. An overview of the adverse reactions to adrenal corticosteroids.
    Frauman AG
    Adverse Drug React Toxicol Rev; 1996 Nov; 15(4):203-6. PubMed ID: 9113247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimum management of glucocorticoid-treated patients.
    Trikudanathan S; McMahon GT
    Nat Clin Pract Endocrinol Metab; 2008 May; 4(5):262-71. PubMed ID: 18349823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical studies on glucocorticoid-induced osteoporosis].
    Tanaka I; Oshima H
    Nihon Rinsho Meneki Gakkai Kaishi; 2001 Aug; 24(4):142-151. PubMed ID: 16646164
    [No Abstract]   [Full Text] [Related]  

  • 4. Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis: 2001 update. American College of Rheumatology Ad Hoc Committee on Glucocorticoid-Induced Osteoporosis.
    Arthritis Rheum; 2001 Jul; 44(7):1496-503. PubMed ID: 11465699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucocorticoid-induced osteoporosis: a review on pathophysiology and treatment options.
    De Nijs RN
    Minerva Med; 2008 Feb; 99(1):23-43. PubMed ID: 18299694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Corticoid long-term therapy. Desired and undesired effects].
    Grabner W
    Fortschr Med; 1973 Apr; 91(12):517-22. PubMed ID: 4702399
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical aspects of anti-inflammatory therapy in asthma.
    Kumar A; Busse WW
    Curr Opin Pulm Med; 1996 Jan; 2(1):40-7. PubMed ID: 9363114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Management of osteoporosis in patients with inhaled glucocorticoids].
    Wada S; Kamiya S; Fukawa T
    Clin Calcium; 2006 Nov; 16(11):1871-77. PubMed ID: 17079855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomic and nongenomic effects of glucocorticoids.
    Stahn C; Buttgereit F
    Nat Clin Pract Rheumatol; 2008 Oct; 4(10):525-33. PubMed ID: 18762788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucocorticoid-induced osteoporosis.
    Tamura Y; Okinaga H; Takami H
    Biomed Pharmacother; 2004 Nov; 58(9):500-4. PubMed ID: 15511606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [New glucocorticoids are more selective. Current knowledge can eliminate serious adverse effects].
    Nilsson S; Gustafsson JA
    Lakartidningen; 1997 Jun; 94(26-27):2465-71. PubMed ID: 9235445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Glucocorticoid induced osteoporosis].
    GutiƩrrez-Polo R
    An Sist Sanit Navar; 2003; 26 Suppl 3():63-80. PubMed ID: 14716359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Glucocorticoid].
    Sato Y; Munakata Y
    Nihon Rinsho; 2012 Aug; 70 Suppl 6():172-7. PubMed ID: 23156504
    [No Abstract]   [Full Text] [Related]  

  • 14. Preventive techniques to limit glucocorticoid-induced side effects.
    Vittorio CC; Werth VP
    Adv Dermatol; 2000; 16():273-97; discussion 298. PubMed ID: 11094631
    [No Abstract]   [Full Text] [Related]  

  • 15. Glucocorticoid-induced osteoporosis in dermatologic practice: a review.
    Khan YK; Kalaaji AN; Clarke BL
    J Drugs Dermatol; 2008 Nov; 7(11):1053-9. PubMed ID: 19110736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Corticosteroid osteoporosis.
    Sambrook P; Lane NE
    Best Pract Res Clin Rheumatol; 2001 Jul; 15(3):401-13. PubMed ID: 11485337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic issues in oral glucocorticoid use.
    Bello CE; Garrett SD
    Lippincotts Prim Care Pract; 1999; 3(3):333-41; quiz 342-4. PubMed ID: 10711134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of long-term glucocorticoids on bone metabolism in systemic lupus erythematosus patients: the prevalence of its anti-inflammatory action upon bone resorption.
    Korczowska I; Olewicz-Gawlik A; Hrycaj P; Lacki J
    Yale J Biol Med; 2003; 76(2):45-54. PubMed ID: 15369631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vertebral fracture and bone mineral density in women receiving high dose glucocorticoids for treatment of autoimmune diseases.
    Kumagai S; Kawano S; Atsumi T; Inokuma S; Okada Y; Kanai Y; Kaburaki J; Kameda H; Suwa A; Hagiyama H; Hirohata S; Makino H; Hashimoto H
    J Rheumatol; 2005 May; 32(5):863-9. PubMed ID: 15868623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhalational and topical steroids, and oral candidosis: a mini review.
    Ellepola AN; Samaranayake LP
    Oral Dis; 2001 Jul; 7(4):211-6. PubMed ID: 11575870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.